Aminocaproic acid

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
220pxpx }}
Aminocaproic acid
Systematic (IUPAC) name
6-aminohexanoic acid
Identifiers
CAS number 60-32-2
ATC code B02AA01
PubChem 564
DrugBank APRD00791
Chemical data
Formula C6H13NO2 
Mol. mass 131.173 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Renal
Half life 2 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

WikiDoc Resources for

Aminocaproic acid

Articles

Most recent articles on Aminocaproic acid

Most cited articles on Aminocaproic acid

Review articles on Aminocaproic acid

Articles on Aminocaproic acid in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Aminocaproic acid

Images of Aminocaproic acid

Photos of Aminocaproic acid

Podcasts & MP3s on Aminocaproic acid

Videos on Aminocaproic acid

Evidence Based Medicine

Cochrane Collaboration on Aminocaproic acid

Bandolier on Aminocaproic acid

TRIP on Aminocaproic acid

Clinical Trials

Ongoing Trials on Aminocaproic acid at Clinical Trials.gov

Trial results on Aminocaproic acid

Clinical Trials on Aminocaproic acid at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Aminocaproic acid

NICE Guidance on Aminocaproic acid

NHS PRODIGY Guidance

FDA on Aminocaproic acid

CDC on Aminocaproic acid

Books

Books on Aminocaproic acid

News

Aminocaproic acid in the news

Be alerted to news on Aminocaproic acid

News trends on Aminocaproic acid

Commentary

Blogs on Aminocaproic acid

Definitions

Definitions of Aminocaproic acid

Patient Resources / Community

Patient resources on Aminocaproic acid

Discussion groups on Aminocaproic acid

Patient Handouts on Aminocaproic acid

Directions to Hospitals Treating Aminocaproic acid

Risk calculators and risk factors for Aminocaproic acid

Healthcare Provider Resources

Symptoms of Aminocaproic acid

Causes & Risk Factors for Aminocaproic acid

Diagnostic studies for Aminocaproic acid

Treatment of Aminocaproic acid

Continuing Medical Education (CME)

CME Programs on Aminocaproic acid

International

Aminocaproic acid en Espanol

Aminocaproic acid en Francais

Business

Aminocaproic acid in the Marketplace

Patents on Aminocaproic acid

Experimental / Informatics

List of terms related to Aminocaproic acid

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Aminocaproic acid (also known as Amicar, є-amino caproic acid, or 6-aminohexanoic acid) is a derivative and analogue of the amino acid lysine, which makes it an effective inhibitor for enzymes which bind that particular residue. Such enzymes include proteolytic enzymes (which break down proteins) including plasminogen, the enzyme responsible for fibrinolysis. For this reason it is effective in treatment of some bleeding disorders and is marketed as Amicar.

Mechanism of action

Aminocaproic acid works as an anti-fibrinolytic or anti-proteolytic. As a lysine analogue, it binds reversibly to the kringle domain of the enzyme plasminogen and blocks binding of fibrin, which is normally activated to plasmin.

Clinical use

Aminocaproic acid is used to treat excessive postoperative bleeding. It can be given orally or intravenously. One scenario where it may be useful is to treat bleeding after dental extractions in patients with hemophilia, because the oral mucosa is rich in plasminogen activators. A meta-analysis found that lysine analogs like aminocaproic acid significantly reduced blood loss in patients undergoing coronary artery bypass grafting.

Side effects

Its side effects are mainly related to the gastrointestinal tract and include nausea, vomiting, abdominal pain, and diarrhea. It may cause generalised myalgia. The main risk associated with aminocaproic acid is the increased risk for thrombosis because of the inhibition of fibrinolysis.

Other uses

Aminocaproic acid is occasionally used in BN-PAGE buffers, not for its effects as a proteolysis inhibitor, but to solubilize membrane proteins in place of sodium chloride (which is incompatible with PAGE in the necessary concentration). Percent recovery of protein complexes increases linearly with the concentration of inhibitor (between 125 mM and 750 mM)[1].

References

  1. Schägger, H and Von Jagow, G (1991). Blue Native Electrophoresis for Isolation of Membrane Protein Complexes in Enzymatically Active Form. Analytical Biochemistry 199 (2): 223-231.

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

In other languages